Results 21 to 30 of about 564 (139)

First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment [PDF]

Scientific Reports, 2023
Immunotherapies based on antibody fragments have been developed and applied to human diseases, describing novel antibody formats. The vNAR domains have a potential therapeutic use related to their unique properties.
Mirna Burciaga-Flores, Ana Laura Márquez-Aguirre, Salvador Dueñas, Jahaziel Gasperin-Bulbarela, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas   +5 more
doaj   +2 more sources

Humanization of the Shark V_NAR Single Domain Antibody Using CDR Grafting. [PDF]

Curr Protoc, 2023
AbstractThe variable domain of the new antigen receptor (VNAR) of shark single domain antibodies is evolutionarily distant from the variable regions (VH) of mammalian immunoglobulins, yet it still has complementarity‐determining regions (CDRs) that are involved in antigen recognition, therefore making it possible to humanize by grafting these CDRs to ...
Zhang YF, Sun Y, Hong J, Ho M.
europepmc   +3 more sources

Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies [PDF]

Frontiers in Immunology, 2020
The B-cell receptor (BCR) is a key player of the adaptive immune system. It is a unique part of immunoglobulin (Ig) molecules expressed on the surface of B cells. In case of many B-cell lymphomas, the tumor cells express a tumor-specific and functionally
Arturo Macarrón Palacios, Julius Grzeschik, Lukas Deweid, Simon Krah, Stefan Zielonka, Thies Rösner, Matthias Peipp, Thomas Valerius, Harald Kolmar   +8 more
doaj   +3 more sources

Novel, Anti-hTNF-α Variable New Antigen Receptor Formats with Enhanced Neutralizing Potency and Multifunctionality, Generated for Therapeutic Development [PDF]

Frontiers in Immunology, 2017
The management of chronic inflammatory diseases, such as inflammatory bowel disease, psoriasis, and rheumatoid arthritis has significantly improved over the last decade with the clinical availability of anti-TNF-α biologics.
Obinna C. Ubah, John Steven, Marina Kovaleva, Laura Ferguson, Charlotte Barelle, Andrew J. R. Porter, Andrew J. R. Porter, Caroline J. Barelle   +7 more
doaj   +4 more sources

VNAR: shark single-domain antibodies for the new era of medical biotechnology [PDF]

Frontiers in Immunology
Shark-derived single-domain antibodies, known as VNARs, represent unique and advanced tools in medical biotechnology. Recognized for their small size, simple structure, and exceptional stability, VNARs can access cryptic epitopes that are inaccessible to
Richard A. Olivares-Olivares, Richard A. Olivares-Olivares, Angélica R. Bravo, Angélica R. Bravo, Carlos Garrido-Soto, Carlos Garrido-Soto, Jonatan J. Carvajal, Jonatan J. Carvajal, Augusto Manubens, Mariella Rivas, Mariella Rivas, Carlos Bustamente, Angello Retamal-Díaz, Angello Retamal-Díaz, Angello Retamal-Díaz, Alexis M. Kalergis, Alexis M. Kalergis, Margarita K. Lay, Margarita K. Lay, Margarita K. Lay   +19 more
doaj   +2 more sources

Novel Approach for Obtaining Variable Domain of New Antigen Receptor with Different Physicochemical Properties from Japanese Topeshark (Hemitriakis japanica) [PDF]

Marine Drugs, 2023
Diverse candidate antibodies are needed to successfully identify therapeutic and diagnostic applications. The variable domain of IgNAR (VNAR), a shark single-domain antibody, has attracted attention owing to its favorable physicochemical properties.
Tomofumi Nakada-Masuta, Hiroyuki Takeda, Kazuhisa Uchida   +2 more
doaj   +2 more sources

Generation of shark single-domain antibodies as an aid for Cryo-EM structure determination of membrane proteins: Use hyaluronan synthase as an example [PDF]

Journal of Structural Biology: X
In cartilaginous fish, the immunoglobulin new antigen receptor (IgNAR) is naturally devoid of light chains. The variable regions of IgNAR (VNARs) are solely responsible for antigen recognition, similar to VHHs (variable domain of the heavy chain of heavy-
Penghui Deng, Xiaoyue Zhang, Jianqing Wen, Mingce Xu, Pengwei Li, Hao Wang, Yunchen Bi   +6 more
doaj   +2 more sources

Yeast Surface Dual Display Platform for Rapid Discovery of Shark VNAR from a Semi-Synthetic Library Followed by Next-Generation Sequencing

Applied Sciences, 2023
The shark-derived single-domain antibody VNAR (variable domain of new antigen receptor) has many advantageous features that make the VNAR suitable for improving current monoclonal antibody therapy deficiencies or disease diagnosis methods.
Chia-Hung Tsai, Kuang-Teng Wang, Xuan Guo, Tsung-Meng Wu   +3 more
doaj   +2 more sources

The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library [PDF]

Communications Biology
Cancer-associated fibroblasts (CAFs) in the stroma of solid tumors promote an immunosuppressive tumor microenvironment (TME) that drives resistance to therapies.
Gihan S. Gunaratne, Joseph P. Gallant, Kendahl L. Ott, Payson L. Broome, Sasha Celada, Jayden L. West, Jason C. Mixdorf, Eduardo Aluicio-Sarduy, Jonathan W. Engle, Eszter Boros, Labros Meimetis, Joshua M. Lang, Shuang G. Zhao, Reinier Hernandez, David Kosoff, Aaron M. LeBeau   +15 more
doaj   +2 more sources

An Anti-hTNF-α Variable New Antigen Receptor Format Demonstrates Superior in vivo Preclinical Efficacy to Humira® in a Transgenic Mouse Autoimmune Polyarthritis Disease Model [PDF]

Frontiers in Immunology, 2019
Tumor necrosis factor-alpha (TNF-α), an established pro-inflammatory cytokine plays a central role in the induction and progression of several chronic inflammatory and autoimmune diseases.
Obinna C. Ubah, John Steven, Andrew J. Porter, Andrew J. Porter, Caroline J. Barelle   +4 more
doaj   +4 more sources